Surgical Tourniquets Market is projected to reach US$ 812.2 by 2029 | FMI Study

FMI’ analysis expects the surgical tourniquets market to grow at ~8% CAGR through to 2029, driven a surge in the number of trauma cases over the years lined with rising demand for effective device to stop arterial bleeding during surgical procedures. Analysts also expect that automatic machines and robotic technologies are likely to bring a paradigm shift …

MRI Pulse Oximeters Market to reach a valuation of US$ 36.5 Million by 2028 | FMI

Global sales of MRI pulse oximeters were valued at ~US$ 31.6 million in 2022, is predicted to increase at a CAGR of 2.5% to reach a valuation of US$ 36.5 Mn by 2028. As per the research findings of a new study by Future Market Insights (FMI), constant technological advancements in medical devices that target improved efficiency and convenience, have been …

Glucose Monitoring Devices Market in USA is expected to register a growth of 16.1% by 2033 | Says FMI Analyst

According to Future Market Insights’ most recent industry report, the global Glucose Monitoring Devices Market was valued at roughly US$ 21.3 Billion in 2022 and is expected to rise at a CAGR close to 16.9% over the forecast period, reaching an estimated worth of US$ 118.1 Billion in 2033. Over the past 20 years, diabetes …

Castration-Resistant Prostate Cancer (CRPC) Treatment Market is expected to reach US$ 28 Billion by 2033, at a CAGR of 9.5%

According to Future Market Insights, the Castration-Resistant Prostate Cancer (CRPC) Treatment Market is predicted to develop at a 9.5% CAGR from 2023 to 2033. The global market for Castration-Resistant Prostate Cancer (CRPC) Treatment is estimated to reach a value of US$ 28 billion by 2033. Growth of the market can be attributed to increasing prevalence …

Atypical Hemolytic Uremic Syndrome (aHUS) Treatment Market to Register 4.9% CAGR from 2023 to 2033 | FMI Study

During the forecast period 2023 to 2033, the Atypical Hemolytic Uremic Syndrome (aHUS) Treatment Market is expected to grow at a value of 4.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Atypical hemolytic uremic syndrome (ahus) treatment is expected to rise up to a market valuation of US$ …

Rosai-Dorfman Disease (RDD) Therapeutics Market is expected to grow with a 6.9% CAGR during 2023 to 2033

According to Future Market Insights, the Rosai-Dorfman Disease (RDD) Therapeutics market is predicted to increase at a 6.9% CAGR from 2023 to 2033. The global market for Rosai-Dorfman Disease (RDD) Therapeutics is estimated to reach US$ 839.95 Million by the year 2033. Advances in diagnostic technologies and the development of novel medicines are projected to …

Gastrointestinal Stromal Tumor (GIST) Therapeutics Market is predicted to reach a valuation of US$ 1593 million with a CAGR of 6% by 2033

The global Gastrointestinal Stromal Tumor (GIST) Therapeutics Market is predicted to generate a market value of US$ 890 million in 2023 and a market value of US$ 1593 million by 2033, with a CAGR of 6% from 2023 to 2033. The increased prevalence of gastrointestinal stromal tumour (GIST) in the world’s ageing population can be …

Dementia Management Market is estimated to reach a valuation of US$ 75.56 million by 2033, with a CAGR of 8% | FMI Analyst

The global Dementia Management Market is expected to garner a market value of US$ 35 Million in 2023 and is expected to accumulate a market value of US$ 75.56 Million by registering a CAGR of 8% in the forecast period 2023 to 2033. The market for Dementia Management registered a CAGR of 5% in the …

Lumbosacral Radicular Pain Management Market is estimated to reach a valuation of US$ 1.4 billion by 2033 | CAGR 5%

The global Lumbosacral Radicular Pain Management Market is predicted to generate a market value of US$ 0.9 billion in 2023 and a market value of US$ 1.4 billion by 2033, with a CAGR of 5% from 2023 to 2033. From 2018 to 2022, the market for Lumbosacral Radicular Pain Management grew at a CAGR of …

Atrophic Vaginitis Treatment Market is predicted to reach US$ 2.78 billion by 2033, rising at an 8% CAGR | FMI Analyst

According to Future Market Insights, the Atrophic Vaginitis Treatment Market is predicted to develop at an 8% CAGR from 2023 to 2033. By 2033, the global market for Atrophic vaginitis treatment is predicted to reach a value of US$ 6 billion. The atrophic vaginitis treatment market is expected to grow significantly in the coming years …